Art Sedrakyan is a Professor at Weill Cornell Medical College and is also leading US Food and Drug Administration’s (FDA) Medical Device Epidemiology (MDEpiNet) Coordinating, Science and Infrastructure Center  http://hpr.weill.cornell.edu/research/mdepinet/mdepinet.html.  see main http://www.mdepinet.org/
At Cornell he also directs the 'Institute for Health Technologies and Interventions'. https://hpr.weill.cornell.edu/research-collaboration/our-divisions/health-technologies-interventions

He is a trained CT surgeon and a graduate of Johns Hopkins University with Ph.D in Health Policy and Management. He was a senior adviser at FDA and had appointments as senior service officer/senior adviser at the Agency for Healthcare Research and Quality (AHRQ) from 2005 to 2009. He was a lead adviser on interventions (including surgery), implantable devices and cardiovascular and orthopedic content areas. Art Sedrakyan initiated the Effective Healthcare Cardiovascular Consortium and supervised centers for Education and Research in Therapeutics (CERTS); Cardiovascular CERT and orthopedic Device CERT.

Prior to appointments at DHHS he worked in the United Kingdom and has registry research, evidence synthesis and teaching experience from Royal College of Surgeons (RCS) of England and London School of Hygiene (LSHTM), where he served as a faculty and was Senior Adviser for National Collaborating Center for Acute Care (part of UK National Institute of Clinical Excellence (NICE)).

He is currently serving as a ranking member and was previously the Vice-Chair of Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). He is serving on MEDCAC from June 1, 2010. http://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/MEDCAC.html. Dr. Sedrakyan is the Vice-Chair of the IDEAL initiative with special interest/leadership area in devices (www.ideal-collaboration.net). The IDEAL is the main international organization dealing with technology innovation and its evaluation. Since January 2017 he is serving as specialist advisor for Australian Therapeutic Good Administration (TGA) and Honorary Professor at the University of New South Wales in Sydney Australia where MDEpiNet chapter is established.